by Truveta Research | Jun 5, 2025 | Research, Research Insights
The percentage of uncemented total knee arthroplasties (TKAs) nearly doubled from 5.7% to 10.3% between 2018 and 2024. Readmission and revision rates were similar between cemented and uncemented TKAs. Cemented TKAs were associated with higher rates of stiffness,...
by Truveta Research | Jun 3, 2025 | Research, Research Insights
In collaboration with Reuters, Truveta Research explored trends in FDA-approved anti-obesity GLP-1 RA prescriptions among adolescents. Among the 1,265,399 adolescents (aged 12-17 years) in this study, the average rate of first-time AOM semaglutide prescriptions was...
by Truveta staff | May 30, 2025 | Research, Research Insights
Authors: Wilson Lau, PhD ⊕Truveta, Inc, Bellevue, WA,, Youngwon Kim, PhD ⊕Truveta, Inc, Bellevue, WA, Sravanthi Paras, MD ⊕Swedish Medical Center, Seattle, WA, Md Enamul Haque, PhD ⊕Truveta, Inc, Bellevue, WA,, Sara Daraei, PhD ⊕Truveta, Inc, Bellevue, WA, Rajesh Rao,...
by Truveta Research | May 30, 2025 | Research, Research Insights
Authors: Patricia J. Rodriguez, PhD, MPH ⊕Truveta, Inc, Bellevue, WA Duy Do, PhD ⊕Truveta, Inc, Bellevue, WA, Brianna M. Goodwin Cartwright, MS ⊕Truveta, Inc, Bellevue, WA, Jennifer Liang, MD ⊕Truveta, Inc, Bellevue, WA, Keenan Robbins, MBBS ⊕Washington University...
by Truveta staff | May 29, 2025 | Research
Each year, more than 34,000 men in the U.S. die from prostate cancer. While early-stage disease is often highly treatable, outcomes still vary widely — especially by race, income, and geography. Catching the disease early can save lives, but real-world data on...
by Truveta staff | May 21, 2025 | Research
A recent analysis using Truveta Data reveals that patients undergoing high-risk, non-emergency heart procedures (percutaneous coronary intervention, or PCI) with support from the Impella heart pump had better outcomes than those supported with an intra-aortic balloon...
